[go: up one dir, main page]

Koyuncu et al., 2023 - Google Patents

Visual assessment of 2-dimensional levels within 3-dimensional pathology data sets of prostate needle biopsies reveals substantial spatial heterogeneity

Koyuncu et al., 2023

View HTML
Document ID
4714894221313547359
Author
Koyuncu C
Janowczyk A
Farre X
Pathak T
Mirtti T
Fernandez P
Pons L
Reder N
Serafin R
Chow S
Viswanathan V
Glaser A
True L
Liu J
Madabhushi A
Publication year
Publication venue
Laboratory Investigation

External Links

Snippet

Prostate cancer prognostication largely relies on visual assessment of a few thinly sectioned biopsy specimens under a microscope to assign a Gleason grade group (GG). Unfortunately, the assigned GG is not always associated with a patient's outcome in part …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation not covered by G01N21/00 or G01N22/00, e.g. X-rays or neutrons
    • G01N23/22—Investigating or analysing materials by the use of wave or particle radiation not covered by G01N21/00 or G01N22/00, e.g. X-rays or neutrons by measuring secondary emission
    • G01N23/225—Investigating or analysing materials by the use of wave or particle radiation not covered by G01N21/00 or G01N22/00, e.g. X-rays or neutrons by measuring secondary emission using electron or ion microprobe or incident electron or ion beam
    • G01N23/2251—Investigating or analysing materials by the use of wave or particle radiation not covered by G01N21/00 or G01N22/00, e.g. X-rays or neutrons by measuring secondary emission using electron or ion microprobe or incident electron or ion beam with incident electron beam
    • G01N23/2252—Investigating or analysing materials by the use of wave or particle radiation not covered by G01N21/00 or G01N22/00, e.g. X-rays or neutrons by measuring secondary emission using electron or ion microprobe or incident electron or ion beam with incident electron beam and measuring excited X-rays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2223/00—Investigating materials by wave or particle radiation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T11/00—2D [Two Dimensional] image generation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T3/00—Geometric image transformation in the plane of the image, e.g. from bit-mapped to bit-mapped creating a different image
    • G06T3/0031—Geometric image transformation in the plane of the image, e.g. from bit-mapped to bit-mapped creating a different image for topological mapping of a higher dimensional structure on a lower dimensional surface
    • G06T3/0037—Reshaping or unfolding a 3D tree structure onto a 2D plane

Similar Documents

Publication Publication Date Title
Liu et al. Harnessing non-destructive 3D pathology
US20220156930A1 (en) Cancer risk stratification based on histopathological tissue slide analysis
Viswanathan et al. The state of the art for artificial intelligence in lung digital pathology
Thomas et al. Evaluating feasibility of an automated 3-dimensional scanner using Raman spectroscopy for intraoperative breast margin assessment
US9298968B1 (en) Digital image analysis of inflammatory cells and mediators of inflammation
Peeken et al. A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
Koyuncu et al. Visual assessment of 2-dimensional levels within 3-dimensional pathology data sets of prostate needle biopsies reveals substantial spatial heterogeneity
Zhang et al. Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study
CN106462767A (en) Examining device for processing and analyzing an image
Fjaellegaard et al. Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis
Sanyal et al. Digital pathology for nonalcoholic steatohepatitis assessment
Ulaganathan et al. A clinicopathological study of various oral cancer diagnostic techniques
Puri et al. Automated computational detection, quantitation, and mapping of mitosis in whole-slide images for clinically actionable surgical pathology decision support
WO2017171720A1 (en) Digital image analysis of inflammatory cells and mediators of inflammation
Ghose et al. 3D reconstruction of skin and spatial mapping of immune cell density, vascular distance and effects of sun exposure and aging
Ptasznik et al. A systematic review of the variability in performing and reporting intraprostatic prostate-specific membrane antigen positron emission tomography in primary staging studies
Forjaz et al. Three-dimensional assessments are necessary to determine the true, spatially-resolved composition of tissues
Schmidt et al. External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens
Karageorgos et al. Deep learning-based automated pipeline for blood vessel detection and distribution analysis in multiplexed prostate cancer images
Al Taher et al. Correlation between imageJ and conventional manual scoring methods for programmed death-ligand 1 immuno-histochemically stained sections
Mahmoud et al. Multi-wavelength interference phase imaging for automatic breast cancer detection and delineation using diffuse reflection imaging
Willenbacher et al. Visible and near-infrared hyperspectral imaging techniques allow the reliable quantification of prognostic markers in lymphomas: A pilot study using the Ki67 proliferation index as an example
Ciaccio et al. Suggestions for automatic quantitation of endoscopic image analysis to improve detection of small intestinal pathology in celiac disease patients
Popp Ex-vivo and in-vivo optical molecular pathology
Liu et al. Nondestructive diagnosis of kidney cancer on 18-gauge core needle renal biopsy using dual-color fluorescence structured illumination microscopy